JP2008526936A - 置換インドールの新規製造方法 - Google Patents

置換インドールの新規製造方法 Download PDF

Info

Publication number
JP2008526936A
JP2008526936A JP2007550831A JP2007550831A JP2008526936A JP 2008526936 A JP2008526936 A JP 2008526936A JP 2007550831 A JP2007550831 A JP 2007550831A JP 2007550831 A JP2007550831 A JP 2007550831A JP 2008526936 A JP2008526936 A JP 2008526936A
Authority
JP
Japan
Prior art keywords
formula
compound
methyl
acetic acid
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526936A5 (cg-RX-API-DMAC7.html
Inventor
フィリップ・キーガン
エリック・メリフィールド
ダンカン・ギル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2008526936A publication Critical patent/JP2008526936A/ja
Publication of JP2008526936A5 publication Critical patent/JP2008526936A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2007550831A 2005-01-13 2006-01-09 置換インドールの新規製造方法 Pending JP2008526936A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500604.4A GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process
PCT/GB2006/000060 WO2006075139A2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles

Publications (2)

Publication Number Publication Date
JP2008526936A true JP2008526936A (ja) 2008-07-24
JP2008526936A5 JP2008526936A5 (cg-RX-API-DMAC7.html) 2009-02-12

Family

ID=34203986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550831A Pending JP2008526936A (ja) 2005-01-13 2006-01-09 置換インドールの新規製造方法

Country Status (15)

Country Link
US (1) US7781598B2 (cg-RX-API-DMAC7.html)
EP (1) EP1844012A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008526936A (cg-RX-API-DMAC7.html)
KR (1) KR20070104350A (cg-RX-API-DMAC7.html)
CN (1) CN101102999B (cg-RX-API-DMAC7.html)
AU (1) AU2006205697B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0606639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2594391A1 (cg-RX-API-DMAC7.html)
GB (1) GB0500604D0 (cg-RX-API-DMAC7.html)
IL (1) IL183965A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007008348A (cg-RX-API-DMAC7.html)
NO (1) NO20074047L (cg-RX-API-DMAC7.html)
NZ (1) NZ556147A (cg-RX-API-DMAC7.html)
WO (1) WO2006075139A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200705216B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532186A (ja) * 2009-07-06 2012-12-13 アストラゼネカ・アクチエボラーグ 4−(アセチルアミノ))−3−[(4−クロロ−フェニル)チオ]−2−メチル−1h−インドール−1−酢酸の製造のための中間体および方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
US7741360B2 (en) 2006-05-26 2010-06-22 Astrazeneca Ab Bi-aryl or aryl-heteroaryl substituted indoles
CN104114169A (zh) 2011-12-16 2014-10-22 阿托佩斯治疗有限公司 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物
CN103288707B (zh) * 2013-05-28 2015-12-23 浙江大学 一种3-苯巯基吲哚衍生物的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013510A1 (en) * 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
WO2004039807A1 (en) * 2002-10-30 2004-05-13 Merck Frosst Canada & Co. Pyridopyrrolizine and pyridoindolizine derivatives
WO2004050085A1 (en) * 2002-12-03 2004-06-17 F. Hoffmann-La Roche Ag Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
WO2004106302A1 (en) * 2003-05-27 2004-12-09 Astrazeneca Ab Novel substituted 3-sulfur indoles

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
BR9405737A (pt) 1993-02-24 1995-12-05 Merck & Co Inc Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017256A1 (es) 1997-08-21 2001-09-05 American Home Prod Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden
EP0924209B1 (en) 1997-12-19 2003-05-02 Eli Lilly And Company Hypoglycemic imidazoline compounds
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
WO2000078761A1 (en) 1999-06-23 2000-12-28 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
HUP0203895A3 (en) 1999-12-24 2004-09-28 Aventis Pharma Ltd West Mallin Substituted azaindoles and pharmaceutical compositions containing them and their use
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
TWI317634B (en) * 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
PL373410A1 (en) 2002-02-01 2005-08-22 F.Hoffman-La Roche Ag Substituted indoles as alpha-1 agonists
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
EP2423190A1 (en) 2002-05-16 2012-02-29 Shionogi&Co., Ltd. Compounds Exhibiting PGD 2 Receptor Antagonism
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
JP2007508363A (ja) 2003-10-14 2007-04-05 オキサジェン リミテッド Crth2アンタゴニスト活性を有する化合物
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
US7741360B2 (en) * 2006-05-26 2010-06-22 Astrazeneca Ab Bi-aryl or aryl-heteroaryl substituted indoles
WO2007140786A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
MX2008015768A (es) 2006-06-28 2009-01-07 Sanofi Aventis Nuevos inhibidores de cxcr2.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013510A1 (en) * 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
WO2004039807A1 (en) * 2002-10-30 2004-05-13 Merck Frosst Canada & Co. Pyridopyrrolizine and pyridoindolizine derivatives
WO2004050085A1 (en) * 2002-12-03 2004-06-17 F. Hoffmann-La Roche Ag Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
WO2004106302A1 (en) * 2003-05-27 2004-12-09 Astrazeneca Ab Novel substituted 3-sulfur indoles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012011130; 日本化学会 編: 新実験化学講座14 有機化合物の合成と反応II , 1977, p.935, 丸善株式会社 *
JPN6012011131; 大河原信 他編: 合成試薬 , 1980, p.248, 株式会社 講談社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532186A (ja) * 2009-07-06 2012-12-13 アストラゼネカ・アクチエボラーグ 4−(アセチルアミノ))−3−[(4−クロロ−フェニル)チオ]−2−メチル−1h−インドール−1−酢酸の製造のための中間体および方法

Also Published As

Publication number Publication date
CN101102999A (zh) 2008-01-09
AU2006205697A1 (en) 2006-07-20
US20080051586A1 (en) 2008-02-28
KR20070104350A (ko) 2007-10-25
NZ556147A (en) 2010-01-29
CN101102999B (zh) 2010-12-29
WO2006075139A3 (en) 2006-10-19
CA2594391A1 (en) 2006-07-20
ZA200705216B (en) 2008-09-25
GB0500604D0 (en) 2005-02-16
WO2006075139A2 (en) 2006-07-20
EP1844012A2 (en) 2007-10-17
BRPI0606639A2 (pt) 2009-07-07
MX2007008348A (es) 2007-08-03
AU2006205697B2 (en) 2009-01-22
IL183965A0 (en) 2007-10-31
NO20074047L (no) 2007-08-06
US7781598B2 (en) 2010-08-24

Similar Documents

Publication Publication Date Title
JP2004518737A (ja) 2−(4−クロロベンゾイルアミノ)−3−[2(1h)−キノールリノン−4−イル]プロピオン酸の製造方法
US7781598B2 (en) Process for the preparation of substituted indoles
US6706890B2 (en) Method for producing oxindoles
JP2682705B2 (ja) 2,6−ジクロロフェニルアミノベンゼン酢酸誘導体及びジフェニルアミン誘導体の製造方法。
AU735516B2 (en) Process for preparing 4-substituted-1H-indole-3-glyoxamides
EP2118058B9 (en) Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
DE69608862T2 (de) Verfahren zur Herstellung einer optisch aktiven 2-Hydroxy-4-Arylbuttersäure oder deren Ester und Zwischenprodukt dafür
WO2012165607A1 (ja) プロリン化合物の製造方法
EP2349998B1 (en) A novel process for the preparation of eletriptan
JPH0978277A (ja) 3−アミノ−2−ヒドロキシ−1,1,1−トリフルオロメチル化合物の製造法
KR20120101553A (ko) 갑상선 호르몬 및 그것의 염의 제조 방법
HU199414B (en) Process for producing substituted indolinone derivatives
US4550165A (en) Process for producing 1,2,5,6-tetrahydro-4H-pyrrolo-[3,2,1-ij]-quinolin-4-one
SK13592001A3 (sk) Syntéza 3-amino-3-arylpropanoátov
US4595755A (en) 5-halo-1,2,3-(1,2-dihydropyrrolo)-4-quinolones
JP3832980B2 (ja) 殺虫活性を有するテトラヒドロフラニル誘導体の新規製造中間体
JPH10195064A (ja) 5−アミノ−1,2,4−チアジアゾール酢酸誘導体(シン異性体)の製造方法
JP4937442B2 (ja) 5−フルオロオキシインドールの製造法
FR2790472A1 (fr) Derives de cyclobutene-3, 4-dione, leur preparation et leur application en therapeutique
KR101059275B1 (ko) 개선된 4-[2-(디-엔-프로필아미노)에틸]-1,3-디하이드로-2에이치-인돌-2-온의 제조 방법
JPH0432064B2 (cg-RX-API-DMAC7.html)
JPS6210062A (ja) 置換されたインドリン類の製造方法
JPH11152282A (ja) 新規なカルボン酸誘導体およびその製造方法
JPH10310568A (ja) N−アルコキシカルボニル−l−アスパラギン
JPS604826B2 (ja) インダゾ−ル酢酸類の製造法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130709